Millipore Sigma Vibrant Logo

444147 HCV NS3/4A Protease, Recombinant, E. coli

FDS (Fiches de données de sécurité), certificats d’analyse (CoA) et de qualité (CoQ), dossiers, brochures et autres documents disponibles.

Synonymes: Hepatitis C Virus NS3/4A Protease, Recombinant, E. coli.

444147
  
Prix en cours de récupération
Le prix n'a pas pu être récupéré
La quantité minimale doit être un multiple de
Maximum Quantity is
À la validation de la commande Plus d'informations
Vous avez sauvegardé ()
 
—
Demander le prix
—
Disponibilité limitée Disponibilité limitée
En stock 
Interrompu(e)
Disponible en quantités limitées
Disponibilité à confirmer
    Pour le restant : Nous vous tiendrons informé
      Pour le restant : Nous vous tiendrons informé
      Nous vous tiendrons informé
      Contacter le Service Clients
      Contact Customer Service

       

      Contacter le Service Clients

      Aperçu

      Replacement Information
      Description
      Overview

      This product has been discontinued.





      Recombinant, human HCV NS3/4A protease expressed in E. coli and purified by affinity chromatography using FPLC. HCV is a positive, single-stranded RNA virus of the Flaviviridae family that encodes a polyprotein precursor of about 3,000 amino acids. It is a common cause of chronic liver disease. HCV NS3/4A is an essential enzyme for viral replication. It is believed that HCV NS3/4A protease could play an important role in a treatment of hepatitis C infection.
      Catalogue Number444147
      Brand Family Calbiochem®
      SynonymsHepatitis C Virus NS3/4A Protease, Recombinant, E. coli.
      References
      ReferencesDe Francesco, R., et al. 2003. Antiviral Res. 58, 1.
      Lamarre, D., et al. 2003. Nature 426, 186.
      Kolykhalov, A. et al. 2000. J. Virol. 74, 2046.
      Blight, K. J., et al. 1998. Antiviral Ther. 3, 71.
      Alter, M. J. 1997. Hepatology 26, 62S.
      Bartenschlager, et al. 1995. J. Virol. 69, 7519.
      Lin, C., and Rice, C. M. 1995. Proc. Natl. Acad. Sci. U.S.A. 92, 7622.
      Grakoui, A., et al. 1993. J. Virol. 67, 2832.
      Hijikata, M., et al. 1993. Proc. Natl. Acad. Sci. U.S.A. 90, 10773.
      Tomei, L., et al. 1993. J. Virol. 67, 4017.
      Product Information
      Unit of DefinitionOne unit is defined as 1 ng of purified protein.
      FormLiquid
      FormulationIn 500 mM KCl, 20 mM Tris-HCl, 1 mM DTT, 0.2 mM EDTA, 20% glycerol, pH 8.0.
      Applications
      Biological Information
      Biological activity20-200 ng is sufficient for an in vitro protease assay
      Purity≥95% by SDS-PAGE
      Concentration Label Please refer to vial label for lot-specific concentration
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Dry Ice Only
      Toxicity Standard Handling
      Storage ≤ -70°C
      Avoid freeze/thaw Avoid freeze/thaw
      Do not freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Packaging Information
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Référence GTIN
      444147 0

      Documentation

      HCV NS3/4A Protease, Recombinant, E. coli Certificats d'analyse

      TitreNuméro de lot
      444147

      Références bibliographiques

      Aperçu de la référence bibliographique
      De Francesco, R., et al. 2003. Antiviral Res. 58, 1.
      Lamarre, D., et al. 2003. Nature 426, 186.
      Kolykhalov, A. et al. 2000. J. Virol. 74, 2046.
      Blight, K. J., et al. 1998. Antiviral Ther. 3, 71.
      Alter, M. J. 1997. Hepatology 26, 62S.
      Bartenschlager, et al. 1995. J. Virol. 69, 7519.
      Lin, C., and Rice, C. M. 1995. Proc. Natl. Acad. Sci. U.S.A. 92, 7622.
      Grakoui, A., et al. 1993. J. Virol. 67, 2832.
      Hijikata, M., et al. 1993. Proc. Natl. Acad. Sci. U.S.A. 90, 10773.
      Tomei, L., et al. 1993. J. Virol. 67, 4017.
      Fiche technique

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision16-June-2008 RFH
      SynonymsHepatitis C Virus NS3/4A Protease, Recombinant, E. coli.
      DescriptionRecombinant, human HCV NS3/4A protease expressed in E. coli and purified by affinity chromatography using FPLC. HCV is a positive, single-stranded RNA virus in the Flaviviridae family that encodes a polyprotein precursor of about 3,000 amino acids. It is a common cause of chronic liver disease. HCV NS3/4A is an essential enzyme for viral replication. It is believed that HCV NS3/4A protease could play an important role in a treatment of hepatitis C patients.
      FormLiquid
      FormulationIn 500 mM KCl, 20 mM Tris-HCl, 1 mM DTT, 0.2 mM EDTA, 20% glycerol, pH 8.0.
      Concentration Label Please refer to vial label for lot-specific concentration
      Purity≥95% by SDS-PAGE
      Biological activity20-200 ng is sufficient for an in vitro protease assay
      Unit definitionOne unit is defined as 1 ng of purified protein.
      Storage Avoid freeze/thaw
      ≤ -70°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing initial thaw, aliquot and freeze (-70°C).
      Toxicity Standard Handling
      ReferencesDe Francesco, R., et al. 2003. Antiviral Res. 58, 1.
      Lamarre, D., et al. 2003. Nature 426, 186.
      Kolykhalov, A. et al. 2000. J. Virol. 74, 2046.
      Blight, K. J., et al. 1998. Antiviral Ther. 3, 71.
      Alter, M. J. 1997. Hepatology 26, 62S.
      Bartenschlager, et al. 1995. J. Virol. 69, 7519.
      Lin, C., and Rice, C. M. 1995. Proc. Natl. Acad. Sci. U.S.A. 92, 7622.
      Grakoui, A., et al. 1993. J. Virol. 67, 2832.
      Hijikata, M., et al. 1993. Proc. Natl. Acad. Sci. U.S.A. 90, 10773.
      Tomei, L., et al. 1993. J. Virol. 67, 4017.